These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 983742)

  • 1. [Treatment of depressive and anxiety neurosis with a new psychotropic drug: Nomifensin].
    Chappa H; Levin E; Moizeszowicz J
    Acta Psiquiatr Psicol Am Lat; 1976 Jun; 22(2):133-8. PubMed ID: 983742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double blind comparative trial of nomifensin and desimipramine in depression. Relationship between treatment and phenylethylamine excretion.
    Acébal E; Subirá S; Spatz J; Faleni R; Merzbacher B; Gales A; Moizeszowicz J
    Eur J Clin Pharmacol; 1976 Jun; 10(2):109-13. PubMed ID: 786670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial with nomifensin, a new antidepressant drug.
    Pecknold JC; Ban TA; Lehmann HE; Klingner A
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):304-8. PubMed ID: 125727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
    Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S
    Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly.
    Moizeszowicz J; Subirá S
    J Clin Pharmacol; 1977 Jan; 17(1):81-3. PubMed ID: 319120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term preventive care in depression: the use of bupropion in patients intolerant of other antidepressants.
    Gardner EA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):157-62. PubMed ID: 6406449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL; Evans KR; Sills TL; Kalali AH
    Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depressive symptomatology and sleep apnea syndrome].
    Pochat MD; Ferber C; Lemoine P
    Encephale; 1993; 19(6):601-7. PubMed ID: 12404778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Follow-up study of quality of life and treatment of eating disorder: dynamics of the depressive and anxiety symptoms].
    Banaś A; Januszkiewicz-Grabias A; Radziwiłłowicz P; Smoczyński S
    Psychiatr Pol; 2002; 36(6 Suppl):323-9. PubMed ID: 12647456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of bifemelane hydrochloride on depressive illness of the elderly.
    Yamagami S; Koide S; Mui K; Perk S; Hirayama E; Kioka T; Soejima K; Inoue K; Nishiwaki S
    Int J Clin Pharmacol Res; 1995; 15(1):1-7. PubMed ID: 7490169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
    Pasquini M; Biondi M; Costantini A; Cairoli F; Ferrarese G; Picardi A; Sternberg C
    Depress Anxiety; 2006; 23(7):441-8. PubMed ID: 16841345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.
    Hung CI; Wang SJ; Liu CY
    Depress Anxiety; 2009; 26(6):583-91. PubMed ID: 19242983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of paroxetine on anxiety and agitation associated with depression.
    Sheehan D; Dunbar GC; Fuell DL
    Psychopharmacol Bull; 1992; 28(2):139-43. PubMed ID: 1387484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of phospholipid liposomes in the treatment of neuropsychological disorders associated with the menopause: a double-blind, randomised, placebo-controlled study.
    Rachev E; Nalbansky B; Kolarov G; Agrosì M
    Curr Med Res Opin; 2001; 17(2):105-10. PubMed ID: 11759177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.